CD63 and neoplasm: Similarly, the CD63, also known as melanoma-associated antigen ME491 or MLA1, is highly expressed at the tissue level in the initial stages of melanoma development but down-regulated in advanced metastatic lesions, suggesting that CD63 is likely a suppressor of tumor progression [40,41].